NCT03494387View on ClinicalTrials.gov

VitamIn and oXygen Interventions and Cardiovascular Events

PHASE4CompletedINTERVENTIONAL
Enrollment

600

Participants

Timeline

Start Date

April 6, 2018

Primary Completion Date

March 1, 2020

Study Completion Date

March 24, 2020

Conditions
Postoperative Cardiac Complication
Interventions
DRUG

Oxygen

80% versus 30% inspiratory oxygen concentration

DRUG

Antioxidants

Antioxidants versus placebo

Trial Locations (4)

2100

Abdominalcentret, Rigshospitalet, Copenhagen

HovedOrtoCentret, Rigshospitalet, Copenhagen

Unknown

Bispebjerg and Frederiksberg Hospital, University of Copenhagen, Copenhagen

Herlev Hospital, Herlev

All Listed Sponsors
lead

University Hospital Bispebjerg and Frederiksberg

OTHER

NCT03494387 - VitamIn and oXygen Interventions and Cardiovascular Events | Biotech Hunter | Biotech Hunter